Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly's GLP-1 outdoes Novo Nordisk's
Eli Lilly's GLP-1 outdoes Novo Nordisk's in trial
Adults taking
Eli
Lilly
's Zepbound lost 47% more weight on average than those on
Novo
Nordisk
's Wegovy,
Lilly
reported from the first head-to-head trial comparing the two blockbuster GLP-1 obesity drugs. Why it matters: The data, which hasn't been peer ...
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Key Takeaways Patients taking Eli Lilly's Zepbound lost more weight on average than those on Novo Nordisk's Wegovy in a new clinical study.Zepbound patients lost an average 20% of their body weight compared with roughly 14% for those on Wegovy.
Lilly’s Zepbound Beats Novo’s Wegovy in Head-to-Head Trial
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters.
1d
on MSN
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company ...
2d
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tsunami warnings lifted
Images of suspect released
Set to return after 20 years
May cut diabetes risk
Recuses himself from case
Nadler to step aside
Billy Long to lead IRS
Winter storm to hit US
Ethics report release blocked
DOJ: Bias against Blacks
Satellites to create eclipses
Social Security chief pick
Medellin cartel leader freed
US trade deficit shrinks
Tops $100K for the first time
Weekly jobless claims rise
Delays oil output hike
Recalls over 205,000 SUVs
Taiwan's pres visits Guam
$10B AI data center in LA
Raw milk recall expands
Syrian rebels capture Hama
SpaceX sets record
Rockefeller tree lights up
Prenatal test spots cancer?
New AI tools for employees
Airlines to pay for delays?
Airbus layoffs
Jury deliberations continue
Meet with lawmakers
Feedback